Search for: "FOREST LABORATORIES" Results 1 - 20 of 376
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Sep 2012, 7:10 am by Broc Romanek
Forest Laboratories Proxy Fight Vindicates Strong Defense Here's a Wachtell Lipton memo I received while I was out on vacation: On Wednesday, Forest Laboratories' shareholders reelected nine out of ten incumbent director nominees, while rejecting three out of dissident Carl Icahn's slate of four directors, despite ISS's recommendation in favor of two of Icahn's nominees. [read post]
21 Feb 2017, 9:37 am by Green and Associates
 In a recent case, Forest Laboratories LLC, located in New York, New York, and its subsidiary, Forest Pharmaceuticals Inc., agreed in December 2016 to pay $38 million to resolve allegations that they violated the False Claims Act by paying "kickbacks" through payments and meals for alleged sham speaking programs to induce physicians to prescribe the drugs Bystolic®, Savella®, and Namenda®. [read post]
21 Feb 2017, 9:37 am by Green and Associates
 In a recent case, Forest Laboratories LLC, located in New York, New York, and its subsidiary, Forest Pharmaceuticals Inc., agreed in December 2016 to pay $38 million to resolve allegations that they violated the False Claims Act by paying "kickbacks" through payments and meals for alleged sham speaking programs to induce physicians to prescribe the drugs Bystolic®, Savella®, and Namenda®. [read post]
14 Dec 2006, 8:40 am
Forest Laboratories said on Thursday it had agreed to acquire Cerexa, a privately held developer of antibiotics, for about $480 million. [read post]
15 Feb 2019, 8:14 am by lbergeson@lawbc.com
Conducted by scientists at Pacific Northwest National Laboratory (PNNL), Oak Ridge National Laboratory (ORNL), and the U.S. [read post]
29 Jun 2012, 1:31 pm by By JANET MORRISSEY
Corporate raider Carl Icahn fired off an angry letter to the board of Forest Laboratories Friday, demanding that it come clean on its succession plans. [read post]
5 Sep 2007, 8:38 pm
Noonan -- The Federal Circuit today affirmed a District Court finding that ANDA filer Ivax Pharmaceuticals and co-Defendant Cipla had not shown by clear and convincing evidence that Forest Laboratories' patent-in-suit for Lexapro ® was invalid. [read post]
12 Nov 2008, 4:09 pm
On Monday, November 10, 2008, Forest Laboratories, Inc. filed a quarterly report with the Securities and Exchange Commission, revealing that it had agreed in principle to a settlement amounting to $65 million in In re: Forest Laboratories, Inc. [read post]
On Wednesday, Forest Laboratories’ shareholders reelected nine out of ten incumbent director nominees, while rejecting three out of dissident Carl Icahn’s slate of four directors, despite ISS’s recommendation in favor of two of Icahn’s nominees. [read post]
On Wednesday, Forest Laboratories’ shareholders reelected nine out of ten incumbent director nominees, while rejecting three out of dissident Carl Icahn’s slate of four directors, despite ISS’s recommendation in favor of two of Icahn’s nominees. [read post]
5 Sep 2007, 6:17 am
Reuters reported on Sept. 5, 2007 that the CAFC upheld the validity of a key patent on Forest Laboratories' blockbuster depression drug Lexapro and confirmed a lower court's decision to block sales of generic forms of the drug made by Ivax (Teva Pharmaceutical Industries Ltd) and Cipla Ltd. [read post]
1 May 2009, 6:25 pm
Forest Laboratories set aside $170 million related to a Justice Department investigation into its marketing and promotion of two antidepressants in the fiscal fourth quarter, when net income slid 46 percent to $92.8 million compared with last year’s fourth quarter. [read post]
21 Dec 2016, 9:00 am
., Board Certified by The Florida Bar in Health Law On December 15, 2016, Forest Laboratories agreed to pay $38 million to resolve a whistle blower’s False Claims Act (FCA) suit involving allegations that it paid kickbacks to doctors who prescribed three of the company’s drugs, the US Department of Justice (DOJ) announced. [read post]
21 Dec 2016, 9:00 am
., Board Certified by The Florida Bar in Health Law On December 15, 2016, Forest Laboratories agreed to pay $38 million to resolve a whistle blower’s False Claims Act (FCA) suit involving allegations that it paid kickbacks to doctors who prescribed three of the company’s drugs, the US Department of Justice (DOJ) announced. [read post]
21 Dec 2016, 9:00 am
., Board Certified by The Florida Bar in Health Law On December 15, 2016, Forest Laboratories agreed to pay $38 million to resolve a whistle blower’s False Claims Act (FCA) suit involving allegations that it paid kickbacks to doctors who prescribed three of the company’s drugs, the US Department of Justice (DOJ) announced. [read post]